High cholesterol affects 1 in 4 U.S. adults and raises the risk of heart attack and stroke. The 4 proven treatment options for managing cholesterol in 2026 are lifestyle changes, statin therapy, non-statin medications, and PCSK9 inhibitors. A cardiologist can help determine the right approach for you.
You may have just received your lab results. Or maybe a family member has been told their LDL levels are too high. Either way, a high cholesterol diagnosis can feel overwhelming — especially when you are not sure what the next step looks like.
The good news is that high cholesterol is one of the most treatable cardiovascular risk factors. According to updated 2026 guidelines from the American College of Cardiology and the American Heart Association, about 80% to 90% of cardiovascular disease is linked to modifiable risk factors. That means what you do next matters. A cardiologist at a cardiology clinic in Brooklyn can help you understand your results, assess your personal risk, and build a treatment plan that fits your life.
Here are the 4 proven treatment options for managing high cholesterol in 2026.
4 Cutting-Edge Treatment Options for Managing High Cholesterol in 2026
1. Therapeutic Lifestyle Changes
Lifestyle changes are the foundation of any cholesterol management plan. Before medications are considered, most guidelines recommend starting here — and for many people, these changes alone can make a meaningful difference.
- Diet: Reducing saturated fats, trans fats, and processed foods lowers LDL cholesterol over time. Prioritizing fiber-rich foods, lean proteins, and healthy fats supports better lipid levels.
- Physical activity: Regular, brisk exercise helps raise HDL (“good”) cholesterol while lowering LDL.
- Weight management: Maintaining a healthy weight reduces strain on the cardiovascular system and improves lipid markers.
- Sleep and tobacco: Getting adequate sleep and avoiding tobacco are equally important. Smoking directly damages blood vessels and accelerates plaque buildup.
You do not have to overhaul your entire life overnight. Small, consistent changes add up — and your care team can help you find a pace that is sustainable.
2. Statin Therapy
Statins remain the most widely prescribed medications for high cholesterol, and for good reason. They work by reducing the liver’s production of LDL cholesterol and have decades of clinical evidence behind them.
The 2026 ACC/AHA guidelines reinforce statin therapy as the first-line medication approach, particularly for those at intermediate to high cardiovascular risk. Your cardiologist will consider your LDL level, your 10- and 30-year risk estimates, and any underlying conditions before recommending a specific statin and dose.
For many patients, statins bring LDL levels down significantly — and the lower your LDL, the lower your risk of heart attack and stroke.
3. Non-Statin Medications: Ezetimibe and Bempedoic Acid
Statins work well for most people, but they are not always enough on their own. When LDL levels remain above target — or when statins cause side effects — non-statin add-on medications offer a proven next step.
Two of the most commonly used options are:
- Ezetimibe: This oral medication reduces the amount of cholesterol absorbed through the digestive system. It is often combined with statin therapy to achieve lower LDL targets.
- Bempedoic acid: A newer oral option that blocks cholesterol production in the liver. It is particularly useful for people who cannot tolerate statins.
These medications have been formally recognized in the updated 2026 cholesterol guidelines and may be recommended at a cardiology clinic in Brooklyn when lifestyle changes and statins alone are not reaching your LDL goals.
4. PCSK9 Inhibitors
For patients at high or very high cardiovascular risk — particularly those with a history of heart attack or stroke — PCSK9 inhibitors offer one of the most powerful LDL-lowering options available.
These injectable medications work by blocking the PCSK9 protein, which allows the liver to clear more LDL cholesterol from the bloodstream. Established options such as evolocumab and alirocumab reduce LDL levels by approximately 60%.
A phase three clinical trial published in the New England Journal of Medicine in February 2026 also showed that an experimental oral PCSK9 inhibitor called enlicitide reduced LDL by up to 60% — the most significant LDL reduction ever achieved with a daily pill. While enlicitide awaits FDA review, it signals an important shift in what is possible for patients who need more than statins alone.
Your Next Step Starts with a Conversation
A high cholesterol diagnosis is not a verdict. It is a starting point — and the right guidance can make all the difference in the outcome.
The 2026 cholesterol guidelines mark the most significant update to cardiovascular care since 2018, with a clear emphasis on earlier screening, personalized treatment, and proactive risk management. Whether you need lifestyle support, medication, or a more advanced treatment plan, the Cardiology team is equipped to walk you through every option.
Reach out today by calling + 1-718-367-2555 or visiting us at 1797 Pitkin Avenue, Brooklyn, NY 11212 to schedule a consultation and take the first step toward protecting your heart health.
